Literature DB >> 21975931

Increased skin papilloma formation in mice lacking glutathione transferase GSTP.

Colin J Henderson1, Kenneth J Ritchie, Aileen McLaren, Probir Chakravarty, C Roland Wolf.   

Abstract

The glutathione S-transferase GSTP is overexpressed in many human cancers and chemotherapy-resistant cancer cells, where there is evidence that GSTP may have additional functions beyond its known catalytic role. On the basis of evidence that Gstp-deficient mice have a comparatively higher susceptibility to skin carcinogenesis, we investigated whether this phenotype reflected an alteration in carcinogen detoxification or not. For this study, Gstp(-/-) mice were interbred with Tg.AC mice that harbor initiating H-ras mutations in the skin. Gstp(-/-)/Tg.AC mice exposed to the proinflammatory phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) exhibited higher tumor incidence and multiplicity with a significant thickening of skin after treatment, illustrating hyperproliferative growth. Unexpectedly, we observed no difference in cellular proliferation or apoptosis or in markers of oxidative stress, although higher levels of the inflammatory marker nitrotyrosine were found in Gstp(-/-)/Tg.AC mice. Instead, gene set enrichment analysis of microarray expression data obtained from skin revealed a more proapoptotic and proinflammatory environment shortly after TPA treatment. Within 4 weeks of TPA treatment, Gstp(-/-)/Tg.AC mice displayed altered lipid/sterol metabolism and Wnt signaling along with aberrant processes of cytoskeletal control and epidermal morphogenesis at both early and late times. In extending the evidence that GSTP has a vital role in normal homeostatic control and cancer prevention, they also strongly encourage the emerging concept that GSTP is a major determinant of the proinflammatory character of the tumor microenvironment. This study shows that the GSTP plays a major role in carcinogenesis distinct from its role in detoxification and provides evidence that the enzyme is a key determinant of the proinflammatory tumor environment. ©2011 AACR

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21975931      PMCID: PMC3218105          DOI: 10.1158/0008-5472.CAN-11-0882

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  51 in total

1.  Polymorphisms in glutathione S-transferases and non-melanoma skin cancer risk in Australian renal transplant recipients.

Authors:  Anthony A Fryer; Helen M Ramsay; Tracy J Lovatt; Peter W Jones; Carmel M Hawley; David L Nicol; Richard C Strange; Paul N Harden
Journal:  Carcinogenesis       Date:  2004-09-30       Impact factor: 4.944

2.  v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid.

Authors:  A Leder; A Kuo; R D Cardiff; E Sinn; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

4.  Glutathione S-transferase polymorphisms and skin cancer after renal transplantation.

Authors:  S E Marshall; C Bordea; N A Haldar; C G Mullighan; F Wojnarowska; P J Morris; K I Welsh
Journal:  Kidney Int       Date:  2000-11       Impact factor: 10.612

5.  Transient activation of beta-catenin signalling in adult mouse epidermis is sufficient to induce new hair follicles but continuous activation is required to maintain hair follicle tumours.

Authors:  Cristina Lo Celso; David M Prowse; Fiona M Watt
Journal:  Development       Date:  2004-04       Impact factor: 6.868

6.  Increased levels of alpha-class and pi-class glutathione S-transferases in cell lines resistant to 1-chloro-2,4-dinitrobenzene.

Authors:  C J Wareing; S M Black; J D Hayes; C R Wolf
Journal:  Eur J Biochem       Date:  1993-10-15

7.  BRAF and NRAS mutations in melanoma: potential relationships to clinical response to HSP90 inhibitors.

Authors:  Udai Banerji; Annette Affolter; Ian Judson; Richard Marais; Paul Workman
Journal:  Mol Cancer Ther       Date:  2008-03-28       Impact factor: 6.261

8.  Identification of direct transcriptional targets of (V600E)BRAF/MEK signalling in melanoma.

Authors:  Leisl M Packer; Philip East; Jorge S Reis-Filho; Richard Marais
Journal:  Pigment Cell Melanoma Res       Date:  2009-08-04       Impact factor: 4.693

9.  GCK is essential to systemic inflammation and pattern recognition receptor signaling to JNK and p38.

Authors:  Jian Zhong; L Cristina Gavrilescu; Arpád Molnár; Lauren Murray; Stephen Garafalo; John H Kehrl; Amy R Simon; Richard A Van Etten; John M Kyriakis
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-25       Impact factor: 11.205

10.  Genetic architecture of mouse skin inflammation and tumour susceptibility.

Authors:  David A Quigley; Minh D To; Jesús Pérez-Losada; Facundo G Pelorosso; Jian-Hua Mao; Hiroki Nagase; David G Ginzinger; Allan Balmain
Journal:  Nature       Date:  2009-01-11       Impact factor: 49.962

View more
  5 in total

1.  Altered protein S-glutathionylation identifies a potential mechanism of resistance to acetaminophen-induced hepatotoxicity.

Authors:  David J McGarry; Probir Chakravarty; C Roland Wolf; Colin J Henderson
Journal:  J Pharmacol Exp Ther       Date:  2015-08-26       Impact factor: 4.030

2.  Identification of deleterious nsSNPs in α, μ, π and θ class of GST family and their influence on protein structure.

Authors:  P Yadav; A Chatterjee; A Bhattacharjee
Journal:  Genom Data       Date:  2014-05-09

3.  Coniferyl Ferulate, a Strong Inhibitor of Glutathione S-Transferase Isolated from Radix Angelicae sinensis, Reverses Multidrug Resistance and Downregulates P-Glycoprotein.

Authors:  Chang Chen; Chuanhong Wu; Xinhua Lu; Zhiyong Yan; Jian Gao; Hui Zhao; Shaojing Li
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-24       Impact factor: 2.629

Review 4.  Comprehensive Review of Methodology to Detect Reactive Oxygen Species (ROS) in Mammalian Species and Establish Its Relationship with Antioxidants and Cancer.

Authors:  Shivkanya Fuloria; Vetriselvan Subramaniyan; Sundram Karupiah; Usha Kumari; Kathiresan Sathasivam; Dhanalekshmi Unnikrishnan Meenakshi; Yuan Seng Wu; Mahendran Sekar; Nitin Chitranshi; Rishabha Malviya; Kalvatala Sudhakar; Sakshi Bajaj; Neeraj Kumar Fuloria
Journal:  Antioxidants (Basel)       Date:  2021-01-18

5.  Novel Pathways of Ponatinib Disposition Catalyzed By CYP1A1 Involving Generation of Potentially Toxic Metabolites.

Authors:  Rumen Kostov; Jeffrey T-J Huang; Colin J Henderson; C Roland Wolf
Journal:  J Pharmacol Exp Ther       Date:  2017-10       Impact factor: 4.030

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.